![Marshall Urist](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marshall Urist
Corporate Officer/Principal bei
ROYALTY PHARMA PLC
Vermögen: 230 Mio $ am 30.06.2026
Profil
Dr. Marshall Urist is a Vice President-Research & Investments at RP Management LLC, an Executive Vice President-Research & Investments at Royalty Pharma Plc and a Head of Research & Investments at Royalty Pharma Manager LLC.
Previously, Dr. Urist was an executive director and the senior biotechnology analyst at Morgan Stanley.
He has a BA, Phi Beta Kappa, from Johns Hopkins University, a PhD from Columbia University and an MD from Columbia University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.04.2026 | 2’474’120 ( 1.03% ) | 139 Mio $ | 30.06.2026 | |
ROYALTY PHARMA PLC 5.53% | 06.04.2026 | 1’356’528 ( 5.53% ) | 76 Mio $ | 30.06.2026 |
RPI US Partners 2019 LP
 RPI US Partners 2019 LP Financial ConglomeratesFinance Functions as an investment fund 0.12% | 07.11.2025 | 247’412 ( 0.12% ) | 14 Mio $ | 30.06.2026 |
| 01.07.2026 | 19’020 ( 0% ) | 1 Mio $ | 30.06.2026 |
Aktive Positionen von Marshall Urist
| Unternehmen | Position | Beginn |
|---|---|---|
| ROYALTY PHARMA PLC | Corporate Officer/Principal | 01.01.2013 |
RP Management LLC
 RP Management LLC Financial ConglomeratesFinance Provides biopharma royalty transactions services | Corporate Officer/Principal | 19.07.2013 |
Ehemalige bekannte Positionen von Marshall Urist
| Unternehmen | Position | Ende |
|---|---|---|
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.07.2013 |
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/
 Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/ Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 31.01.2006 |
Ausbildung von Marshall Urist
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
99
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/ Investment Banks/BrokersFinance Provides brokerage services | Finance |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RP Management LLC
RP Management LLC Financial ConglomeratesFinance Provides biopharma royalty transactions services | Finance |
Royalty Pharma Plc
 Royalty Pharma Plc Pharmaceuticals: MajorHealth Technology Buys and operates a portfolio of biopharmaceutical royalties | Health Technology |
Wählen Sie MarketScreener 
